Complete PET/CT extinction and subsequent risk of aortic dilation in patients with giant cell arteritis-related large vessel vasculitis treated with tocilizumab

Background The proportion of patients with giant cell arteritis (GCA)-related large vessel vasculitis (LVV) treated with tocilizumab (TCZ) who achieve a complete metabolic response on repeated 18 F-fluorodeoxyglucose positron emission tomography (18FDG-PET)-CT (PET/CT) is unknown.Methods We conducte...

Повний опис

Бібліографічні деталі

Автори:	Laurent Sailler, Maxime Samson, Hubert de Boysson, Samuel Deshayes, Achille Aouba, Jean-Francois Alexandra, Nicolas Martin-Silva, Emilie Berthoux, Jonathan Boutémy, Olivier Espitia, Anael Dumont, Gwenola Maigne, Chloé Comarmond-Ortoli, Marie Morard, Sophie Gallou, Rémi Philip, Claire Delacotte
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMJ Publishing Group 2026-03-01
Серія:	RMD Open
Онлайн доступ:	https://rmdopen.bmj.com/content/12/1/e006563.full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!